REQUEST A DEMO
Total
USD $0.00
Search more companies

Tramag Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Other Depository Credit Intermediation | All Other Nondepository Credit Intermediation | Other Activities Related to Credit Intermediation | All Other Insurance Related Activities | Administrative Management and General Management Consulting Services | All Other Miscellaneous Ambulatory Health Care Services
Full name: Tramag Sp. z o.o. Profile Updated: September 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Tramag Sp. z o.o. is based in Poland, with the head office in Warsaw. The enterprise operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on May 07, 2020. From the latest financial highlights, Tramag Sp. z o.o. reported a net sales revenue drop of 58.33% in 2023. Over the same period, its total assets grew by 8.05%. The net profit margin of Tramag Sp. z o.o. increased by 11.03% in 2023.

Headquarters
Ul. Postepu 21B
Warsaw; Mazowieckie; Postal Code: 02-676

Contact Details: Purchase the Tramag Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Tramag Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Tramag Sp. z o.o. report to view the information.
Incorporation Date:
May 07, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
58.56%
Purchase this report to view the information.
17.72%
Purchase this report to view the information.
13.81%
Company Performance
Financial values in the chart are available after Tramag Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-58.33%
Total operating revenue
-58.33%
Operating profit (EBIT)
66.44%
Net Profit (Loss) for the Period
66.44%
Total assets
8.05%
Total equity
139.6%
Operating Profit Margin (ROS)
11.03%
Net Profit Margin
11.03%
Return on Equity (ROE)
81.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?